Author

Meitham Amereh

University of VictoriaORCID 0000-0002-5035-9244Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Amir SeyfooriiD· 1 shared Julian J. LumiD· 1 shared Mahdieh Shokrollahi BaroughiD· 1 shared Mohsen AkbariiD· 1 shared Patrick B. WalteriD· 1 shared Sarah Lane· 1 shared Shahla ShojaeiiD· 1 shared Tian ZhaoiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Amir SeyfooriORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Metabolic Vulnerabilities of Temozolomide-Resistant Glioblastoma Cells: Implications for Targeted Therapies and Overcoming Chemoresistance

Meitham Amereh, Amir Seyfoori, Shahla Shojaei, Sarah Lane, Tian Zhao, Mahdieh Shokrollahi Barough, Julian J. Lum, Patrick B. Walter, Mohsen Akbari

The paper identifies metabolic vulnerabilities in TMZ-resistant glioblastoma cells, showing that iron reduction enhances the efficacy of TMZ through mechanisms involving Hif1, autophagy, and ROS.

Advanced Science · Apr 26, 2025Peer-reviewedCancer Biology